About us
Who we are
Our strategy
How we are funded
Our people
Reports and statements
Governance and structure
Our impact
Working with us
Support for MRC researchers
Helping charities
Our partners
Available technologies
Advise & Connect: Covid-19
Funding
LifeArc Ventures
Rare disease research funding
Development Gap Fund
Capabilities
Drug discovery
Antibody humanisation
IP management and technology transfer
Diagnostics development
Careers
Working at LifeArc
Our culture
Benefits and rewards
How to apply
Job vacancies
Fellowships
Industrial Placements
News
Latest news
Case studies
Reports and publications
Newsletter
Covid-19 Information
Media contacts
Contact us
Biotherapeutics
Catch up with the latest news and developments from LifeArc
LifeArc joins forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to strengthen antimicrobial discovery efforts
🎬 That's a wrap for this year's
@ELRIG_UK
#DrugDiscovery
conference! Thanks to everyone who came by our exhibition…
https://t.co/VpNz7YqS4l
Filter by:
All
News Releases
Articles & blogs
Ventures Funding
15 August 2022
Anti-netrin 1 human Ab for the treatment of atherosclerosis
15 August 2022
GalR2 agonists for the Treatment of Pain
15 August 2022
Beta amyloid-targeted therapeutic antibody
15 August 2022
Anti Plexin B1 antibody for the treatment of Multiple Sclerosis
15 August 2022
Anti Plexin B1 antibody for the treatment of Osteoporosis
My Interest
Academic Scientist
Pharma/Biotech
Medical Charity
MRC Scientist
Research Organisation